Globus Medical, Inc. (GMED)
NYSE: GMED · Real-Time Price · USD
58.17
-0.08 (-0.14%)
At close: May 14, 2025, 4:00 PM
58.70
+0.53 (0.91%)
After-hours: May 14, 2025, 4:57 PM EDT
Globus Medical Revenue
Globus Medical had revenue of $598.12M in the quarter ending March 31, 2025, a decrease of -1.41%. This brings the company's revenue in the last twelve months to $2.51B, up 32.26% year-over-year. In the year 2024, Globus Medical had annual revenue of $2.52B with 60.62% growth.
Revenue (ttm)
$2.51B
Revenue Growth
+32.26%
P/S Ratio
3.15
Revenue / Employee
$473,738
Employees
5,300
Market Cap
7.88B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.52B | 950.88M | 60.62% |
Dec 31, 2023 | 1.57B | 545.63M | 53.34% |
Dec 31, 2022 | 1.02B | 64.74M | 6.76% |
Dec 31, 2021 | 958.10M | 169.06M | 21.43% |
Dec 31, 2020 | 789.04M | 3.67M | 0.47% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
GMED News
- 23 hours ago - Medical, Inc. Company Investigated by the Portnoy Law Firm - GlobeNewsWire
- 5 days ago - Globus Medical, Inc. (GMED) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 6 days ago - Globus Medical Reports First Quarter 2025 Results - GlobeNewsWire
- 27 days ago - Globus Medical Schedules First Quarter Earnings Release and Conference Call - GlobeNewsWire
- 5 weeks ago - Globus Medical completes acquisition of Nevro Corp. - GlobeNewsWire
- 7 weeks ago - NEVRO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Nevro Corp. - NVRO - Business Wire
- 2 months ago - Globus Medical extends versatility of Advanced Materials Science™ anterior interbody portfolio with launch of COHERE™ ALIF Spacer and Modulus™ ALIF Blades - GlobeNewsWire
- 2 months ago - Globus Medical to feature ExcelsiusFlex™ for Total Knee Arthroplasty at the American Academy of Orthopedic Surgeons Annual Meeting - GlobeNewsWire